Searchable abstracts of presentations at key conferences in endocrinology

ea0058p035 | Miscellaneous Endocrinology | BSPED2018

Use of recombinant human growth hormone in a neonate with Prader Willi Syndrome to improve respiratory status

Shaunak Meera , Dimitrova Svilena , Bridges Nicola , Bhandari Jasjit

Background: Prader Willi Syndrome (PWS) is a disorder of genetic imprinting caused by uniparental disomy of chromosome 15. It can present in the neonatal period with dysmorphic features, hypotonia and feeding difficulties. In the UK, recombinant human Growth Hormone (rhGH) is licensed for use in PWS, improving body composition and motor development, as well as final adult height. Some studies have also demonstrated an improvement in respiratory function in children with PWS. T...